Staar Surgical Co (STAA) — SEC Filings
Staar Surgical Co (STAA) — 50 SEC filings. Latest: DEFA14A (Dec 19, 2025). Includes 20 DEFA14A, 18 8-K, 6 10-Q.
View Staar Surgical Co on SEC EDGAR
Overview
Staar Surgical Co (STAA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a DEFA14A filed on Dec 19, 2025: STAAR Surgical Company (STAAR) filed a DEFA14A on December 19, 2025, indicating that Alcon has exercised its right to require STAAR to repurchase certain shares. The filing is a definitive additional material, and no fee was required for this filing.
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 2 bullish, 2 bearish, 46 neutral. The dominant filing sentiment for Staar Surgical Co is neutral.
Filing Type Overview
Staar Surgical Co (STAA) has filed 20 DEFA14A, 18 8-K, 6 10-Q, 1 10-K, 3 SC 13G/A, 1 8-K/A, 1 DEF 14A with the SEC between Apr 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of STAA's 43 recent filings, 2 were flagged as high-risk, 13 as medium-risk, and 28 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $181.641M |
| Net Income | -$62.139M |
| Cash Position | $176.155M |
Key Executives
- Chief Executive Officer
- C. Robert Muchmore
Industry Context
The ophthalmic surgical device market, particularly for refractive procedures like those involving STAAR Surgical's lenses, is competitive and driven by technological innovation and patient demand for vision correction. Companies in this space often face rigorous regulatory scrutiny and require substantial R&D investment. The proposed merger with Alcon, a major player in the eye care industry, suggests a trend towards consolidation or strategic partnerships to gain market share and leverage scale.
Top Tags
proxy-statement (13) · sec-filing (10) · corporate-governance (5) · financials (5) · 8-k (4) · acquisition (4) · merger (4) · 10-Q (4) · ophthalmic-goods (3) · filing-update (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Filing Date | 12/16/2025 | Date of DEFA14A filing |
| Press Release Date | 12/15/2025 | Date of press release included in filing |
| SEC File Number | 0-11634 | STAAR Surgical Company's SEC file number |
| EIN | 95-3797439 | STAAR Surgical Company's Employer Identification Number |
| IRS Employer Identification Number | 95-3797439 | Company identifier |
| Commission File Number | 0-11634 | Company identifier |
| Net Loss | $62.139M | For nine months ended Sept 26, 2025, compared to $14.020M net income in prior year. |
| Net Sales | $181.641M | For nine months ended Sept 26, 2025, down 31.4% from $264.951M in prior year. |
| Restructuring & Impairment Charges | $27.938M | For nine months ended Sept 26, 2025, significantly impacting profitability. |
| Merger Transaction Costs | $5.926M | For nine months ended Sept 26, 2025, related to the proposed Alcon merger. |
| Per Share Merger Price | $28.00 | Cash offer from Alcon for each STAAR Surgical common stock share. |
| Cash and Cash Equivalents | $176.155M | As of September 26, 2025, an increase from $144.159M at December 27, 2024. |
| Company Termination Fee | $43.4M | Potential fee STAAR Surgical may pay Alcon if merger agreement is terminated under specified circumstances. |
| Alcon Termination Fee | $72.4M | Potential fee Alcon may pay STAAR Surgical if merger agreement is terminated under certain circumstances. |
| Common Shares Outstanding | 49,741,953 | As of October 31, 2025. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Staar Surgical Co (STAA)?
Staar Surgical Co has 50 recent SEC filings from Apr 2024 to Dec 2025, including 20 DEFA14A, 18 8-K, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of STAA filings?
Across 50 filings, the sentiment breakdown is: 2 bullish, 2 bearish, 46 neutral. The dominant sentiment is neutral.
Where can I find Staar Surgical Co SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Staar Surgical Co (STAA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Staar Surgical Co?
Key financial highlights from Staar Surgical Co's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for STAA?
The investment thesis for STAA includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Staar Surgical Co?
Key executives identified across Staar Surgical Co's filings include Chief Executive Officer, C. Robert Muchmore.
What are the main risk factors for Staar Surgical Co stock?
Of STAA's 43 assessed filings, 2 were flagged high-risk, 13 medium-risk, and 28 low-risk.
What are recent predictions and forward guidance from Staar Surgical Co?
Forward guidance and predictions for Staar Surgical Co are extracted from SEC filings as they are enriched.